Protocol No.UW24068
Principal InvestigatorMiller, Megan
PhaseN/A
Age GroupAdult
Management Group(s) Palliative Care

Title
Perceptions and Attitudes related to Psilocybin-Assisted Therapy among Cancer Patients who Have been Underrepresented in Research (PATH)

Description
Perceptions and Attitudes related to Psilocybin-Assisted Therapy among Cancer Patients who Have been Underrepresented in Research (PATH)

Objective
Primary: The purpose of this study is to qualitatively explore perceptions and attitudes related to PAT among people with cancer who have been underrepresented in research (Black/African American people, people with limited educational attainment, and people at this intersection). This work intends to generate initial collective themes across these underrepresented groups, allowing future exploration of subgroup differences.

Treatment Psilocybin-assisted therapy (PAT) is a promising intervention for addressing psychospiritual symptoms associated with cancer. Evidence supports feasibility and initial efficacy of PAT, yet results are limited in their generalizability due to homogenous and non-representative samples. This study aims to explicitly incorporate the voices of people with cancer who have been underrepresented in prior studies (people of color, people with limited educational attainment, and people at this intersection). A qualitative descriptive design will be used, ultimately identifying a set of categories and subcategories representing participants’ most common attitudes and perceptions about PAT.

Key Eligibility Inclusion criteria:



    age >/=18;

    Current diagnosis of cancer (any type or stage [except stage 0 and low risk skin cancers – basal and squamous cell]);

    Able to read, write, and speak English;

    Self-identified as one or both of the following…


      Black or African American

      And/Or Highest educational attainment is completion of high school/GED.

Applicable Disease Sites
Anal; Any Site; Bladder; Brain/Central Nervous System; Breast; Cervix; Colon and Rectum; Endocrine cancers; Esophagus; Gastrointestinal cancers, other; Genitourinary cancers, other; Head and Neck; Hematologic cancers, other; Ill-Defined Sites; Kidney; Leukemia; Liver; Lung; Lymphoma; Melanoma/Skin cancer; Multiple Myeloma; Ovary; Pancreas; Prostate; Sarcoma; Stomach; Thyroid; Unknown Sites; Uterus

Participating Institutions
UW Health Eastpark Medical Center; UW Health University Hospital